<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35687535</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1536-4801</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of pediatric gastroenterology and nutrition</Title><ISOAbbreviation>J Pediatr Gastroenterol Nutr</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 Liver Manifestation in Children.</ArticleTitle><Pagination><StartPage>244</StartPage><EndPage>251</EndPage><MedlinePgn>244-251</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MPG.0000000000003521</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Severe acute respiratory syndrome coronavirus 2, the novel coronavirus responsible for coronavirus disease (COVID-19), has been a major cause of morbidity and mortality worldwide. Gastrointestinal and hepatic manifestations during acute disease have been reported extensively in the literature. Post-COVID-19 cholangiopathy has been increasingly reported in adults. In children, data are sparse. Our aim was to describe pediatric patients who recovered from COVID-19 and later presented with liver injury.</AbstractText><AbstractText Label="METHODS">This is a retrospective case series study of pediatric patients with post-COVID-19 liver manifestations. We collected data on demographics, medical history, clinical presentation, laboratory results, imaging, histology, treatment, and outcome.</AbstractText><AbstractText Label="RESULTS">We report 5 pediatric patients who recovered from COVID-19 and later presented with liver injury. Two types of clinical presentation were distinguishable. Two infants aged 3 and 5 months, previously healthy, presented with acute liver failure that rapidly progressed to liver transplantation. Their liver explant showed massive necrosis with cholangiolar proliferation and lymphocytic infiltrate. Three children, 2 aged 8 years and 1 aged 13 years, presented with hepatitis with cholestasis. Two children had a liver biopsy significant for lymphocytic portal and parenchyma inflammation, along with bile duct proliferations. All 3 were started on steroid treatment; liver enzymes improved, and they were weaned successfully from treatment. For all 5 patients, extensive etiology workup for infectious and metabolic etiologies was negative.</AbstractText><AbstractText Label="CONCLUSIONS">We report 2 distinct patterns of potentially long COVID-19 liver manifestations in children with common clinical, radiological, and histopathological characteristics after a thorough workup excluded other known etiologies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Shiri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobar</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Department of Pathology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konen</LastName><ForeName>Osnat</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Institute of Imaging, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orenstein</LastName><ForeName>Naama</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Genetics Unit, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kropach Gilad</LastName><ForeName>Nesia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Genetics Unit, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landau</LastName><ForeName>Yuval E</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Metabolic Diseases Clinic, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mozer-Glassberg</LastName><ForeName>Yael</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar-Lev</LastName><ForeName>Michal Rozenfeld</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>From the Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaoul</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>the Gastroenterology Institute, Rambam Medical Center, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shamir</LastName><ForeName>Raanan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waisbourd-Zinman</LastName><ForeName>Orith</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>From the Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Gastroenterol Nutr</MedlineTA><NlmUniqueID>8211545</NlmUniqueID><ISSNLinking>0277-2116</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2023 Mar 1;76(3):e70. doi: 10.1097/MPG.0000000000003689</RefSource><PMID Version="1">36574220</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2023 Mar 1;76(3):e69. doi: 10.1097/MPG.0000000000003688</RefSource><PMID Version="1">36574266</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017114" MajorTopicYN="Y">Liver Failure, Acute</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>13</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35687535</ArticleId><ArticleId IdType="doi">10.1097/MPG.0000000000003521</ArticleId><ArticleId IdType="pii">00005176-202209000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, et al. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: a review. JGH Open 2021;5:1257&#x2013;65.</Citation></Reference><Reference><Citation>Garland V, Kumar AB, Borum ML. gastrointestinal and hepatic manifestations of COVID-19: evolving recognition and need for increased understanding in vulnerable populations. J Natl Med Assoc 2021;113:142&#x2013;6.</Citation></Reference><Reference><Citation>Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020;39:355&#x2013;68.</Citation></Reference><Reference><Citation>Guimar&#xe3;es D, Pissarra R, Reis-Melo A, et al. Multisystem inflammatory syndrome in children (MISC): a systematic review. Int J Clin Pract 2021;75:e14450.</Citation></Reference><Reference><Citation>Perez A, Cantor A, Rudolph B, et al. Liver involvement in children with SARS-COV-2 infection: two distinct clinical phenotypes caused by the same virus. Liver Int 2021;41:2068&#x2013;75.</Citation></Reference><Reference><Citation>Orandi BJ, Li G, Dhall D, et al. Acute liver failure in a healthy young female with COVID-19. JPGN Rep 2021;2:e108.</Citation></Reference><Reference><Citation>Antala S, Diamond T, Kociolek LK, et al. Severe hepatitis in pediatric COVID-19. J Pediatr Gastroenterol Nutr 2022;74:631&#x2013;35.</Citation></Reference><Reference><Citation>Durazo FA, Nicholas AA, Mahaffey JJ, et al. Post-COVID-19 cholangiopathy-a new indication for liver transplantation: a case report. Transplant Proc 2021;53:1132&#x2013;7.</Citation></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol 2021;116:1077&#x2013;82.</Citation></Reference><Reference><Citation>Faruqui S, Okoli FC, Olsen SK, et al. Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Am J Gastroenterol 2021;116:1414&#x2013;25.</Citation></Reference><Reference><Citation>Meersseman P, Blondeel J, De Vlieger G, et al. Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients. Intensive Care Med 2021;47:1037&#x2013;40.</Citation></Reference><Reference><Citation>B&#xfc;tikofer S, Lenggenhager D, Wendel Garcia PD, et al. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int 2021;41:2404&#x2013;17.</Citation></Reference><Reference><Citation>Tafreshi S, Whiteside I, Levine I, et al. A case of secondary sclerosing cholangitis due to COVID-19. Clin Imaging 2021;80:239&#x2013;42.</Citation></Reference><Reference><Citation>Klindt C, Jensen B, Brandenburger T, et al. Secondary sclerosing cholangitis as a complication of severe COVID19: a case report and review of the literature. Clin Case Rep 2021;9:e04068.</Citation></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Zapata E, et al. Cholangiopathy as part of post-COVID syndrome. J Transl Autoimmun 2021;4:100116.</Citation></Reference><Reference><Citation>Bartoli A, Gitto S, Sighinolfi P, et al. Primary biliary cholangitis associated with SARS-CoV-2 infection. J Hepatol 2021;74:1245&#x2013;6.</Citation></Reference><Reference><Citation>Sgouropoulou V, Vargiami E, Kyriazi M, et al. Transient severe liver injury: a unique presentation of COVID-19 disease in a pediatric patient. Pediatr Infect Dis J 2021;40:e204&#x2013;5.</Citation></Reference><Reference><Citation>Verheijen J, Wong SY, Rowe JH, et al. Defining a new immune deficiency syndrome: MAN2B2-CDG. J Allergy Clin Immunol 2020;145:1008&#x2013;11.</Citation></Reference><Reference><Citation>Edwards K, Allison M, Ghuman S. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Reports CP 2020;13:e237984.</Citation></Reference><Reference><Citation>UK Health Security Agency Technical briefing. Investigation into acute hepatitis of unknown aetiology in children in England. Version 1.0. GOV-12265. 2022. Available at: https://www.gov.uk/government/publications/acute-hepatitis-technical-briefing . Accessed May 21, 2022.</Citation></Reference><Reference><Citation>Caramaschi S, Kapp ME, Miller SE, et al. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol 2021;34:1614&#x2013;33.</Citation></Reference><Reference><Citation>European centre for disease prevention and control. Rapid risk assessment: increase in severe acute hepatitis cases of unknown aetiology in children. Stockholm: ECDC, 2022. Available at: https://www.ecdc.europa.eu/en/publications-data/increase-severe-acute-hepatitis-cases-unknown-aetiology-children . Accessed May 21, 2022.</Citation></Reference><Reference><Citation>Zaki SR, Alves VAF, Hale GL. Non-hepatotropic viral, bacterial, and parasitic infections of the liver. macsween&#x2019;s pathology of the liver. Philadelphia, PA: Elsevier, 2018:416&#x2013;90.</Citation></Reference><Reference><Citation>Marsh K, Tayler R, Pollock L, et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill 2022;27:2200318.</Citation></Reference><Reference><Citation>Brodin P, Arditi M. Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens. Lancet Gastroenterol Hepatol 2022;7:594&#x2013;95</Citation></Reference><Reference><Citation>Zhang H, Kang Z, Gong H, et al. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut 2020;69:1010&#x2013;8.</Citation></Reference><Reference><Citation>Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv 2020. Available at: https://doi.org/10.1101/2020.02.03.931766 . Accessed July 24 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.03.931766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B, Ni C, Gao R, et al. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell 2020;11:771&#x2013;5.</Citation></Reference><Reference><Citation>Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol 2020;190:29&#x2013;31.</Citation></Reference><Reference><Citation>Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2. N Engl J Med 2020;382:2574&#x2013;6.</Citation></Reference><Reference><Citation>Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid 2021;31:8&#x2013;11.</Citation></Reference><Reference><Citation>Lin YL, Askonas BA. Biological properties of an influenza a virus-specific killer t cell clone. inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 1981;154:225&#x2013;34.</Citation></Reference><Reference><Citation>Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 2020;16:413&#x2013;4.</Citation></Reference><Reference><Citation>George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med 2014;5:69&#x2013;86.</Citation></Reference><Reference><Citation>Kayaaslan BU, Asilturk D, Eser F, et al. A case of hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature. J Infect Dev Ctries 2021;15:1607&#x2013;14.</Citation></Reference><Reference><Citation>Giacalone M, Scheier E, Shavit I. Multisystem inflammatory syndrome in children (MIS-C): a mini-review. Int J Emerg Med 2021;14:50.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>